NCT00126399View on ClinicalTrials.gov

A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

April 30, 2005

Conditions
Rosacea
Interventions
DRUG

doxycycline

Sponsors
All Listed Sponsors
lead

CollaGenex Pharmaceuticals

INDUSTRY

NCT00126399 - A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea | Biotech Hunter | Biotech Hunter